Physician

Nathan Brantley Wyatt, M.D.

According to 2025 Medicare claims, Nathan Wyatt, M.D. (NPI: 1396989786) practices neurology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is ADVANCED DIAGNOSTIC IMAGING, PC (NPI: 1093741464; TIN: 620874165) and primary practice location at 37404-3909. Wyatt is affiliated with the Ascension Care Management (ACO ID: A1061) and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Wyatt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 615 traditional Medicare patients, billed 43,455 HCPCS/CPT codes, and received $1,263,457 in Medicare payments. The top billing code was 95910 (Nerve conduction, 7-8 studies). Part D data shows 4,407 prescription claims across 522 beneficiaries totaling $1,849,203 in drug costs, led by Evrysdi (Risdiplam). DME data shows 87 claims. Open Payments data shows 184 records totaling $3,298. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $175,089 to $1,263,457. Similarly, Part D prescription costs have risen steadily, from $161,722 to $1,849,203. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $341 to $52,007.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	553	11,359	$175,089
2016	666	17,172	$207,398
2017	680	18,372	$258,346
2018	663	20,623	$356,719
2019	612	29,964	$595,513
2020	531	32,888	$642,642
2021	463	27,064	$756,236
2022	485	32,703	$599,692
2023	554	37,161	$794,570
2024	615	43,455	$1,263,457

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	223	1,272	$161,722
2016	318	2,208	$442,649
2017	385	2,745	$439,930
2018	413	3,309	$1,317,948
2019	426	3,920	$1,324,364
2020	419	3,990	$1,436,926
2021	415	3,968	$1,620,364
2022	420	3,977	$1,796,964
2023	460	4,159	$1,940,487
2024	522	4,407	$1,849,203

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	15	$250
2016	N/R	N/R	N/R
2017	N/R	11	$51,663
2018	N/R	13	$61,056
2019	N/R	27	$68,722
2020	N/R	25	$63,323
2021	N/R	26	$62,159
2022	N/R	30	$74,169
2023	N/R	121	$225,445
2024	N/R	87	$325,458

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95910	Nerve conduction, 7-8 studies	87	87	$123
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	112	112	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	179	208	$82
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	226	415	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	185	215	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Evrysdi	Risdiplam	16	384	$445,107
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	47	1,316	$428,972
Nuplazid	Pimavanserin Tartrate	26	1,050	$164,817
Vumerity	Diroximel Fumarate	14	420	$140,403
Aimovig Autoinjector	Erenumab-Aooe	69	2,200	$55,339

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1566	Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg	N	N/R	18	$170,612
J7340	Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml	N	N/R	25	$126,093
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	25	$27,184
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	19	$1,569

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	184	$3,298	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nathan Brantley Wyatt, M.D.?

Tedicare shows public-source Medicare data for Nathan Brantley Wyatt, M.D. (NPI 1396989786), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan Brantley Wyatt, M.D. have ACO affiliation data?

Nathan Brantley Wyatt, M.D. is shown with ACO affiliation data for Ascension Care Management (MSSP, ACO ID A1061) and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Nathan Brantley Wyatt, M.D.?

Nathan Brantley Wyatt, M.D. is linked to ADVANCED DIAGNOSTIC IMAGING, PC (billing NPI 1093741464) in the available physician profile data.

Does Nathan Brantley Wyatt, M.D. have Open Payments data?

Nathan Brantley Wyatt, M.D. has 184 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.